CHAMPIONS ONCOLOGY, INC. financial data

Symbol
CSBR on Nasdaq
Location
Baltimore, MD
Fiscal year end
30 April
Latest financial report
10-Q - Q3 2025 - 15 Dec 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 95% % 44%
Debt-to-equity 630% %
Return On Equity 59% % -11%
Return On Assets 8.1% %
Operating Margin 3.7% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13,886,326 shares 0.48%
Common Stock, Shares, Outstanding 13,886,326 shares 1.4%
Entity Public Float $15,400,000 USD -30%
Common Stock, Value, Issued $14,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 13,791,913 shares 1.5%
Weighted Average Number of Shares Outstanding, Diluted 14,457,837 shares 3.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $58,424,000 USD 9.1%
Research and Development Expense $8,380,000 USD 14%
Selling and Marketing Expense $7,968,000 USD 14%
General and Administrative Expense $10,467,000 USD 5.3%
Operating Income (Loss) $2,150,000 USD -75%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $2,356,000 USD -65%
Income Tax Expense (Benefit) $75,000 USD -92%
Net Income (Loss) Attributable to Parent $2,492,000 USD -63%
Earnings Per Share, Basic 0.18 USD/shares -60%
Earnings Per Share, Diluted 0.18 USD/shares -60%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $8,516,000 USD 209%
Accounts Receivable, after Allowance for Credit Loss, Current $11,539,000 USD 10%
Assets, Current $21,332,000 USD 51%
Operating Lease, Right-of-Use Asset $4,348,000 USD -23%
Goodwill $335,000 USD 0%
Other Assets, Noncurrent $196,000 USD 5.9%
Assets $30,162,000 USD 20%
Accounts Payable, Current $5,993,000 USD 23%
Accrued Liabilities, Current $2,188,000 USD -2.1%
Contract with Customer, Liability, Current $12,338,000 USD 21%
Liabilities, Current $22,141,000 USD 17%
Operating Lease, Liability, Noncurrent $3,744,000 USD -30%
Other Liabilities, Noncurrent $46,000 USD -86%
Liabilities $25,931,000 USD 5.6%
Retained Earnings (Accumulated Deficit) $80,121,000 USD 2.9%
Stockholders' Equity Attributable to Parent $4,170,000 USD 512%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4,231,000 USD 521%
Liabilities and Equity $30,162,000 USD 20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $600,000 USD 93%
Net Cash Provided by (Used in) Financing Activities $14,000 USD 62%
Net Cash Provided by (Used in) Investing Activities $46,000 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 14,006,659 shares 1.4%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $540,000 USD 97%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8,516,000 USD 209%
Deferred Tax Assets, Valuation Allowance $14,838,000 USD -18%
Deferred Tax Assets, Gross $14,838,000 USD -18%
Operating Lease, Liability $5,269,000 USD -22%
Payments to Acquire Property, Plant, and Equipment $46,000 USD
Lessee, Operating Lease, Liability, to be Paid $9,531,000 USD -24%
Property, Plant and Equipment, Gross $16,330,000 USD 0.76%
Operating Lease, Liability, Current $1,525,000 USD 8.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,816,000 USD -3.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,869,000 USD -2.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.0583 pure -0.85%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4,262,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,364,000 USD -18%
Deferred Tax Assets, Operating Loss Carryforwards $8,248,000 USD -8.7%
Unrecognized Tax Benefits $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,392,000 USD -17%
Depreciation, Depletion and Amortization $1,467,000 USD -19%
Share-based Payment Arrangement, Expense $844,000 USD -7.2%